NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer

NCT00937560

CompletedPhase 2

Sponsor: Hoffmann-La Roche

Conditions: Ovarian Cancer

Interventions: Bevacizumab, Paclitaxel, Carboplatin

Countries: Brazil, France, Italy, Netherlands, Norway, Russia, Spain, Sweden

This single arm study evaluated the efficacy and safety of first-line chemotherapy with carboplatin and dose-dense weekly paclitaxel plus bevacizumab (Avastin) in participants with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Participants received 6-8 3-week cycles of treatment with bevacizumab 7.5 mg/kg intravenously (iv) on Day 1 of each cycle, paclitaxel 80 mg/m\^2 iv on days 1, 8, and 15 of each cycle, and carboplatin iv to an area under the curve (AUC) of 6 on day 1 of each cycle. Following combination chemotherapy, bevacizumab could be continued to be given as a monotherapy.

Eligibility overview

Sex: FEMALE

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria

* Female patients, ≥ 18 years of age.
* Epithelial ovarian, fallopian tube, or primary peritoneal cancer.
* Initial surgery, but no chemotherapy or radiotherapy.
* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.

Exclusion Criteria

* Non-epithelial tumors.
* Ovarian tumors with low malignant potential.
* Previous systemic anti-cancer therapy for ovarian cancer.
* History or evidence of synchronous primary endometrial cancer.
* Current or recent daily treatment with aspirin (\> 325mg/day) or with full dose anticoagulant or thrombolytic agents for therapeutic purposes.
Locations (55)
  • Jaú, São Paulo, Brazil
  • São Paulo, São Paulo, Brazil
  • Avignon, France
  • Bordeaux, France
  • Bordeaux, France
  • Brive-la-Gaillarde, France
  • Clamart, France
  • Dijon, France
  • Gap, France
  • Grenoble, France
  • Marseille, France
  • Metz-Tessy, France
  • Nice, France
  • Paris, France
  • Paris, France
  • Poitiers, France
  • Saint-Priest-en-Jarez, France
  • Strasbourg, France
  • Toulouse, France
  • Vandœuvre-lès-Nancy, France
  • Naples, Campania, Italy
  • Modena, Emilia-Romagna, Italy
  • Rome, Lazio, Italy
  • Campobasso, Molise, Italy
  • Alkmaar, Netherlands
  • Amsterdam, Netherlands
  • Enschede, Netherlands
  • Groningen, Netherlands
  • Leidschendam, Netherlands
  • Tilburg, Netherlands
  • + 25 more on CT.gov